Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO

30 Apr 2024

Abstract excerpt

PURPOSE: The relevance of cardiotoxicity in the context of HER2-positive breast cancer is likely to increase with increasing patient treatment exposure, number of treatment lines, and prolonged survival. Circulating biomarkers to early identify patients at risk of cardiotoxicity could allow personalized treatment and follow-up measures. The aim of this study is to examine the relationship between circulating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers in Disease Mechanisms
Share to Chemotherapy-induced cardiotoxicity and mitigation
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38689174
DOI: 10.1007/s10549-024-07299-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTOPMID 38689174Read ↗

microRNAs linked to anthracycline-induced cardiotoxicity in breast cancer patients' female partners: a meta-analysis and route studySemantic proximity Read ↗

Circulating MicroRNA as Biomarkers of Anthracycline-Induced CardiotoxicitySemantic proximity Read ↗

Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicitySemantic proximity Read ↗

Bioinformatic Analysis of Peripheral Blood miRNA of Breast Cancer Patients in Relation With Anthracycline CardiotoxicitySemantic proximity Read ↗

Prevalence and Effects of Late Cardiotoxicity induced by Anthracyclines and/or Anti- HER2 Antibodies in Patients with Breast Cancer: a real world studySemantic proximity Read ↗

The association between early‐onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple‐negative breast cancer patients and some novel autophagy‐related polymorphisms in their genomic DNA: a real‐world studySemantic proximity Read ↗

Risk of heart disease following breast cancer: results from a population-based cohort studySemantic proximity Read ↗

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advancesSemantic proximity Read ↗

Left Atrial Volume Index, Other Systolic and Diastolic Transthoracic Echocardiographic Parameters as Early Predictors for Asymptomatic Trastuzumab Target Cancer Therapy-Related Cardiac Dysfunction among HER2-Positive Breast Cancer Patients at a Tertiary Medical Center in Metro Manila – a Single-Center Prospective Cohort StudySemantic proximity Read ↗

Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer without Risk Factors of Cardiotoxicity. Possibility of Omitting Cardiac Monitoring during Treatment.Semantic proximity Read ↗

Anthracycline-induced cardiotoxicity associates with a shared gene expression response signature to TOP2-inhibiting breast cancer drugs in cardiomyocytesSemantic proximity Read ↗

MicroRNA implications in chemotherapy-induced cardiac toxicitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.